Hamish Douglass

Magellan High Conviction Fund acts as open-end investment fund and unit trust. Its investment objective is to achieve attractive risk-adjusted returns over the medium to long-term through investment in a concentrated portfolio of high-quality companies. The company is headquartered in Sydney, Australia.

Part of Deutsche Bank AG, Deutsche Bank Australia Ltd. is a financial institution based in Sydney, Australia. The Australian company provides information on its legal form, authorized representatives, address, contact information, and other regulatory and mandatory information. The CEOs of the private company are Glenn Morgan, Michael Ormaechea, Rod Everitt.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

MFF Capital Investments Ltd. is a closed-end investment fund. It provides investment services in a minimum of twenty exchange listed international and Australian companies. The company was founded on October 19, 2006 and is headquartered in Sydney, Australia.

Magellan Asset Management Ltd. (dba MFG Asset Management) is the wholly owned asset management subsidiary of Magellan Financial Group Ltd. (ASX: MFG) in Australia. The firm was founded by Hamish Douglass and Chris Mackay in 2006. Headquartered in Sydney, MFG Asset Management offers global equity, infrastructure and global sustainable investment strategies to institutional investors located throughout the world and intermediated investors in Australia and New Zealand. The firm also manages these strategies in segregated, advisory, sub-advisory relationships and via globally focused investment funds for institutional and retail investors internationally.

The Victor Chang Cardiac Research Institute is a research center dedicated to finding cures for heart disease through world-class and cutting-edge medical research. The institute is located in Western Australia and is the first dedicated center of heart research in the region. The scientists at the institute are urgently working to discover better ways of understanding, diagnosing, treating, and preventing the onset of heart disease. The CEO of the Australian company is Mark Rodrick Granger Johnson.